Getty (NYSE:GETY) announced this morning that it will redeem all outstanding warrants for $0.01 per warrant at 5 p.m. on October 19.
This move is not being accompanied by a warrant exchange offer because of just how hot the de-SPAC has been trading over the past month. Getty is allowed to redeem warrants at this price because its stock has finished at or above $18 for 20 of 30 trading days ending on the third date prior to when it gave this notice.
Getty, in fact, hit a high of $37.88 on August 2 and generally traded above $20 for that entire month. Because of this, many of its outstanding warrants may have already been exercised and holders will still be allowed to do so until the redemption date. It is far less attractive to do so now, however, as Getty has slumped to a market open of $8.44 this morning.
There is still time for it to bounce back up, but warrant holders do not appear to be hopeful of this as its warrants (NYSE:GETY.WT) are down -84% to $0.06 on the news. Any unexercised warrants will automatically be redeemed for $0.01 on October 19.
Getty initially announced its combination with CC Neuberger Principal Holdings II on December 10, 2021 and it began trading as a de-SPAC on July 25. With its warrant overhang about to be eliminated, this marks one of the quickest and cleanest transitions from announcement, to close, to a warrant call in some time.
The Seattle-based company serves about 1 million customers, licensing them visual content from about 450,000 contributors covering about 160,000 news, sport and entertainment events annually.
Last month, it announced it generated $74.1 million in EBITDA from $233.3 million in revenue in the second quarter of 2022 and recently inked a multi-year extension of its partnership with Amazon (NASDAQ:AMZN), making Getty content accessible on its various digital platforms.
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...
In June 2025, the SPAC market was marked by a notable rise in meeting delays, with adjournments and postponements playing a central role in extension activity, as sponsors navigated a more cautious market environment. Still, several SPACs secured shareholder approvals, and seven business combinations were completed during the month. At the same time, IPO issuance...
An In-Depth Look at SPAC Activity Through the Second Quarter & First Half 2025 Below is a summary of the first half of 2025 SPAC market. If you’d like a pdf copy, you can access the link HERE. Q2 kicked off in chaos. President Trump’s shifting and often contradictory tariff announcements sent markets reeling, driving...
At the SPAC of Dawn The market is set to be showered with new SPACs today as three more SPACs priced their IPOs overnight, bringing 2025’s total to 66, already surpassing the full-year total of 2024. After hours, Ribbon (NASDAQ:RIBB) also added a new SPAC deal to June’s tally just under the wire, bringing the...